Cargando…

Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis

OBJECTIVES: Moxifloxacin (MXF) has been advocated for the treatment of extensively drug-resistant (XDR) tuberculosis despite resistance to older-generation fluoroquinolones. We investigated the relationship between the minimum inhibitory concentration (MIC) of MXF and mutations in the gyrA and gyrB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dookie, Navisha, Sturm, A Willem, Moodley, Prashini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149401/ https://www.ncbi.nlm.nih.gov/pubmed/25187730 http://dx.doi.org/10.2147/IDR.S65417

Ejemplares similares

Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa
por: Dookie, Navisha, et al.
Publicado: (2016)

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
por: Dookie, Navisha, et al.
Publicado: (2018)

Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa
por: Shah, N. Sarita, et al.
Publicado: (2011)

Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment
por: Perumal, Rubeshan, et al.
Publicado: (2023)

Minimal Diversity of Drug-Resistant Mycobacterium tuberculosis Strains, South Africa
por: Gandhi, Neel R., et al.
Publicado: (2014)

Spread of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South Africa
por: Moodley, Prashini, et al.
Publicado: (2011)

Strains of Mycobacterium tuberculosis differ in affinity for human osteoblasts and alveolar cells in vitro
por: Sarkar, Shrabanti, et al.
Publicado: (2016)

Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field
por: Dookie, Navisha, et al.
Publicado: (2022)

Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing
por: Dookie, Navisha, et al.
Publicado: (2020)

Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model
por: Gupta, U.D., et al.
Publicado: (2015)

Reduced Virulence of an Extensively Drug-Resistant Outbreak Strain of Mycobacterium tuberculosis in a Murine Model
por: Smith, Kristen L. Jurcic, et al.
Publicado: (2014)

Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013
por: Xia, Hui, et al.
Publicado: (2021)

Potassium zinc borate, KZnB(3)O(6)
por: Wu, Yang, et al.
Publicado: (2010)

Extensively Drug-Resistant Mycobacterium tuberculosis, India
por: Mondal, Rajesh, et al.
Publicado: (2007)

ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections
por: Chindelevitch, Leonid, et al.
Publicado: (2016)

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains in geriatrics: An analysis and its implications in tuberculosis control
por: Verma, Ajoy Kumar, et al.
Publicado: (2022)

Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
por: Lee, Jinwoo, et al.
Publicado: (2011)

Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis
por: Yun, Hwi-Yeol, et al.
Publicado: (2021)

Investigation of optical and electrical properties of the semiconducting α-KZnPO(4) compound
por: Chakchouk, N., et al.
Publicado: (2022)

Whole genome analysis of extensively drug resistant Mycobacterium tuberculosis strains in Peru
por: Santos-Lazaro, David, et al.
Publicado: (2021)

Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Electronic Properties of Fluoride and Half–fluoride Superlattices KZnF(3)/KAgF(3) and SrTiO(3)/KAgF(3)
por: Yang, Xiaoping, et al.
Publicado: (2015)

Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults
por: Guan, Yanmin, et al.
Publicado: (2020)

Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance
por: Lale Ngema, Senamile, et al.
Publicado: (2023)

Challenges with Surveillance of Healthcare-Associated Infections in Intensive Care Units in South Africa
por: Mahomed, Saajida, et al.
Publicado: (2017)

Stability of a monovalent rotavirus vaccine after exposure to different temperatures observed in KwaZulu-Natal, South Africa
por: Asowata, Osaretin Emmanuel, et al.
Publicado: (2019)

The role of moxifloxacin in tuberculosis therapy
por: Gillespie, Stephen H.
Publicado: (2016)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

The Regulation of ManLAM-Related Gene Expression in Mycobacterium tuberculosis with Different Drug Resistance Profiles Following Isoniazid Treatment
por: Yimcharoen, Manita, et al.
Publicado: (2022)

Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner
por: Iacobino, Angelo, et al.
Publicado: (2021)

Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India
por: Tornheim, Jeffrey A, et al.
Publicado: (2021)

Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia
por: Dymova, Maya A, et al.
Publicado: (2014)

The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of Mycobacterium tuberculosis as Determined in a Hollow-Fiber Infection Model
por: Drusano, G. L., et al.
Publicado: (2010)

Super-compact treatment with a high dose of moxifloxacin in patients with drug-resistant tuberculosis and its resistance mechanisms
por: WANG, QINGJIANG, et al.
Publicado: (2015)

Determinants of Symptomatic Vulvovaginal Candidiasis among Human Immunodeficiency Virus Type 1 Infected Women in Rural KwaZulu-Natal, South Africa
por: Apalata, Teke, et al.
Publicado: (2014)

Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
por: Kusmiati, Tutik, et al.
Publicado: (2022)

Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis
por: Sidamo, Temesgen, et al.
Publicado: (2022)

Beijing genotype of Mycobacterium tuberculosis is associated with extensively drug-resistant tuberculosis: A global analysis
por: Keikha, M., et al.
Publicado: (2021)

Extensively Drug-Resistant Mycobacterium tuberculosis from Aspirates, Rural South Africa
por: Heysell, Scott K., et al.
Publicado: (2010)

Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015
por: Merker, Matthias, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_chk11f7661q51p6neqsgo11bq0